List view / Grid view
29 March 2016 | By Victoria White
Using a technique called COBRA, researchers created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza strains...
29 March 2016 | By Victoria White
Inovio has updated its clinical strategy to take its INO-3112 HPV immunotherapy into human studies in combination with selected molecules from MedImmune...
29 March 2016 | By Victoria White
Researchers used feedback system control to quickly narrow combinations of 14 different tuberculosis drugs with five different doses into several promising combination treatments...
29 March 2016 | By Victoria White
Dr Yong-Jun Liu has been appointed as Sanofi’s new Head of Research, Global R&D, effective...
24 March 2016 | By Victoria White
Apogenix’s APG101 rescues the production of red blood cells (erythropoiesis) in bone marrow samples from patients with lower-risk myelodysplastic syndromes...
24 March 2016 | By Victoria White
Iterum has also secured a $40 million Series A financing, which will be used for the licensing and product development activities...
23 March 2016 | By Victoria White
In a study, despite eating a high-fat diet for 3 months, miR-155 knockout mice did not become obese and had enhanced metabolic rates...
23 March 2016 | By Victoria White
Researchers have identified mutations in NSCLC that are key to tumour growth, offering a new way to differentiate patients with the disease...
23 March 2016 | By Victoria White
Padlock Therapeutics is a private biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases...
22 March 2016 | By Victoria White
Scientists have provided the first direct evidence of how proteins of the ABC-F family 'protect' the bacterial ribosome from being blocked by antibiotics...
22 March 2016 | By Victoria White
The Human Vaccines Project is focused on cross-sector collaboration to identify human immune responses associated with optimal vaccine protection...
22 March 2016 | By Victoria White
The treatment is designed to inhibit the activity of a protein called PAK-1, which contributes to the development of highly invasive prostate cancer cells...
22 March 2016 | By Victoria White
Inovio’s DNA vaccine and dMAb products show potential to offer immediate and long term protection to large populations from CHIKV infection...
22 March 2016 | By Victoria White
Celyad is teaming up with the Inserm Unit of Institut Curie in Paris, France, to further develop its NKR-T pipeline in cellular immunotherapies for cancer...
21 March 2016 | By Victoria White
The discovery, a crucial step in bacteria's energy metabolism, may be the first step in developing an entirely novel form of antibiotics...
